# Isovanillin

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/isovanillin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-20
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** 3-hydroxy-4-methoxybenzaldehyde, m-vanillin, 3-methoxy-4-hydroxybenzaldehyde, isovanillic aldehyde, IVA, meta-vanillin

## Overview

Isovanillin (3-hydroxy-4-methoxybenzaldehyde) is a naturally occurring phenolic aldehyde found in vanilla beans and various plant sources that exerts antioxidant and [anti-inflammatory](/ingredients/condition/inflammation) effects primarily through [free radical scaveng](/ingredients/condition/antioxidant)ing and inhibition of aldehyde oxidase enzymes. Research suggests it modulates oxidative stress pathways and suppresses pro-inflammatory mediators, though most evidence remains at the preclinical stage.

## Health Benefits

• Exhibits antioxidant properties, potentially beneficial in reducing [oxidative stress](/ingredients/condition/antioxidant) (Preliminary evidence).
• Shows [anti-inflammatory](/ingredients/condition/inflammation) effects in research studies (Preliminary evidence).
• Demonstrates [antimicrobial](/ingredients/condition/immune-support) activity (Preliminary evidence).
• Functions as an aldehyde oxidase inhibitor, useful in pharmaceutical research (Preliminary evidence).
• Potential cytotoxic effects through tubulin ligand synthesis, relevant in cancer research (Preliminary evidence).

## Mechanism of Action

Isovanillin scavenges [reactive oxygen species](/ingredients/condition/antioxidant) (ROS) by donating hydrogen atoms via its hydroxyl group on the aromatic ring, directly neutralizing superoxide and hydroxyl radicals. It inhibits aldehyde oxidase (AOX1), a molybdoflavoenzyme involved in xenobiotic [metabolism](/ingredients/condition/weight-management), which can influence the bioactivation and clearance of certain drugs and endogenous aldehydes. Additionally, it suppresses pro-[inflammatory](/ingredients/condition/inflammation) signaling by downregulating NF-κB pathway activation and reducing production of cytokines such as TNF-α and IL-6 in macrophage cell models.

## Clinical Summary

The majority of evidence for isovanillin comes from in vitro cell culture studies and rodent models, with no large-scale human clinical trials published to date. In vitro [antioxidant](/ingredients/condition/antioxidant) assays (DPPH, FRAP) demonstrate measurable radical-scavenging capacity comparable to related vanillin analogs. Animal studies using murine [inflammation](/ingredients/condition/inflammation) models have shown reductions in paw edema and inflammatory markers at doses ranging from 10–50 mg/kg body weight, but direct translation to human dosing remains unestablished. The overall evidence base is preliminary, and claims regarding human health benefits require validation through controlled clinical trials.

## Nutritional Profile

Isovanillin (3-hydroxy-4-methoxybenzaldehyde; C₈H₈O₃, MW 152.15 g/mol) is a phenolic aldehyde compound, an isomer of vanillin. It is not a nutritional substance and has no macronutrient, vitamin, or mineral profile. Its bioactive properties stem from its phenolic hydroxyl group at the meta position and methoxy group at the para position, which confer [antioxidant](/ingredients/condition/antioxidant) radical-scavenging capacity. Typical research concentrations range from 10–500 µM in vitro. Oral bioavailability data in humans is limited, but structurally related methoxybenzaldehydes (e.g., vanillin) show moderate intestinal absorption with rapid Phase II conjugation (glucuronidation and sulfation), suggesting isovanillin likely undergoes similar first-pass [metabolism](/ingredients/condition/weight-management), reducing free-form bioavailability to an estimated 20–40%.

## Dosage & Preparation

No clinically studied dosage ranges or forms are available. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Isovanillin has not been formally evaluated for safety in human clinical trials, and no established tolerable upper intake level exists. As an aldehyde oxidase inhibitor, it may theoretically alter the [metabolism](/ingredients/condition/weight-management) of drugs cleared by AOX1, including zaleplon, ziprasidone, and certain anticancer agents such as methotrexate, potentially raising their plasma concentrations. Individuals taking medications metabolized via AOX1 should exercise caution and consult a healthcare provider before use. Pregnancy and lactation safety data are absent, and use is not recommended in these populations until further research is available.

## Scientific Research

No human clinical trials or meta-analyses have been conducted on isovanillin, as per the available research. Current evidence is limited to in vitro studies, and no PMIDs are provided.

## Historical & Cultural Context

There is no evidence of historical or traditional medicinal use for isovanillin. It is primarily recognized in modern applications as a fragrance and synthetic compound.

## Synergistic Combinations

Isovanillin pairs well with (1) curcumin (150–500 mg), as both compounds target NF-κB-mediated [inflammatory pathway](/ingredients/condition/inflammation)s through complementary mechanisms—isovanillin via aldehyde oxidase inhibition and curcumin via IKK suppression—amplifying anti-inflammatory effects; (2) piperine (5–20 mg), which inhibits hepatic glucuronidation and CYP3A4 [metabolism](/ingredients/condition/weight-management), likely enhancing isovanillin's bioavailability similarly to its well-documented effect on curcumin; (3) N-acetylcysteine (NAC, 300–600 mg), which replenishes [glutathione](/ingredients/condition/detox) pools and synergizes with isovanillin's antioxidant phenolic radical scavenging to provide multi-layered [oxidative stress](/ingredients/condition/antioxidant) protection; and (4) quercetin (100–500 mg), a flavonoid that complements isovanillin's [antimicrobial](/ingredients/condition/immune-support) and anti-inflammatory activity by co-targeting tubulin polymerization dynamics and inhibiting LOX/COX pathways, potentially enhancing the cytotoxic selectivity observed in preliminary cancer cell studies.

## Frequently Asked Questions

### What is isovanillin and where does it come from?

Isovanillin (3-hydroxy-4-methoxybenzaldehyde) is a phenolic aldehyde and structural isomer of vanillin, occurring naturally in vanilla beans (Vanilla planifolia), certain grasses, and other plant species. It belongs to the hydroxybenzaldehyde family of phenolic compounds and can also be synthesized chemically from guaiacol or isolated via plant extraction for research purposes.

### What are the antioxidant effects of isovanillin?

Isovanillin demonstrates free radical scavenging activity in standardized in vitro assays including DPPH and ABTS, attributed to the phenolic hydroxyl group that donates hydrogen atoms to neutralize reactive oxygen species. Studies show it can reduce markers of lipid peroxidation such as malondialdehyde (MDA) in cell models subjected to oxidative stress. However, these findings are exclusively preclinical and have not been confirmed in human trials.

### Does isovanillin have anti-inflammatory properties?

Preclinical research indicates isovanillin suppresses inflammatory responses by inhibiting NF-κB signaling and reducing production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6 in lipopolysaccharide (LPS)-stimulated macrophage models. Rodent studies have observed reductions in carrageenan-induced paw edema at doses of approximately 10–50 mg/kg. No human clinical data currently confirm these anti-inflammatory effects.

### Can isovanillin interact with medications?

Isovanillin inhibits aldehyde oxidase (AOX1), an enzyme involved in phase I metabolism of multiple pharmaceuticals including zaleplon (a sleep aid), ziprasidone (an antipsychotic), and methotrexate (a chemotherapy and immunosuppressant drug). Inhibiting AOX1 may slow the clearance of these drugs, potentially elevating plasma levels and increasing the risk of adverse effects. Anyone taking AOX1-metabolized medications should consult a physician before using isovanillin-containing supplements.

### Is isovanillin safe to take as a supplement?

No established human safety data, recommended dosage, or tolerable upper limit for isovanillin supplementation currently exists, as no formal clinical trials have evaluated its safety profile in humans. Animal toxicology studies have generally shown low acute toxicity at moderate doses, but chronic exposure data are limited. Isovanillin supplementation is not recommended for pregnant or breastfeeding individuals, and anyone with liver conditions or on polypharmacy should seek medical advice given its aldehyde oxidase-inhibiting activity.

### What food sources naturally contain isovanillin?

Isovanillin is found naturally in vanilla pods, vanilla beans, and certain spices, though typically in small amounts compared to its structural isomer vanillin. It also occurs in some fermented foods and aged products where vanilla-containing ingredients are used. However, dietary sources of isovanillin are generally limited, making supplementation the primary way to achieve meaningful intake levels for health purposes.

### How does isovanillin compare to vanillin in terms of biological activity?

Isovanillin and vanillin are structural isomers with different functional group positions, leading to distinct biological activities. While both exhibit antioxidant properties, isovanillin shows unique aldehyde oxidase inhibitory activity that vanillin does not possess, making it valuable for pharmaceutical research applications. Current preliminary evidence suggests isovanillin may have different potencies in anti-inflammatory and antimicrobial effects compared to vanillin, though direct comparative studies are limited.

### What does current clinical research reveal about isovanillin's effectiveness in humans?

Most evidence for isovanillin comes from preliminary laboratory and animal studies rather than large-scale human clinical trials, with documented antioxidant, anti-inflammatory, and antimicrobial properties. The research quality remains limited, and human efficacy data is sparse, meaning safe and effective dosages for supplementation have not been firmly established through rigorous clinical studies. Additional well-designed human trials are needed to translate these preliminary findings into clinical recommendations for supplement use.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*